World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
22574
World Ranking
2384
National Ranking
1141

Overview

Hans Schreiber is affiliated with the University of Chicago in the United States. Their research spans several fields, primarily focused on Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. The more specific subfields of their work include Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Biotechnology.

The scientist's work predominantly addresses topics related to CAR-T cell therapy research, immunotherapy and immune responses, monoclonal and polyclonal antibodies research, cancer research and treatments, virus-based gene therapy research, nanowire synthesis and applications, and cancer immunotherapy and biomarkers.

Hans Schreiber has contributed to various peer-reviewed journals with frequent publications in the Journal for ImmunoTherapy of Cancer and Cancer Research, as well as individual contributions to Proceedings of the National Academy of Sciences, Human Gene Therapy, and Matter.

Representative recent papers authored or co-authored by Hans Schreiber include:

  • "Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides," 2020, Proceedings of the National Academy of Sciences
  • "LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models," 2020, Human Gene Therapy
  • "Antigen multimers: Specific, sensitive, precise, and multifunctional high-avidity CAR-staining reagents," 2021, Matter
  • "Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens," 2020, Carcinogenesis
  • "One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication," 2024, Clinical Cancer Research

The scientist collaborates frequently with other researchers. Notable frequent co-authors include Steven P. Wolf, Karin Schreiber, Kazuma Kiyotani, Matthias Leisegang, and Vasiliki Anastasopoulou.

Best Publications

  • Innate and adaptive immune cells in the tumor microenvironment

    Thomas F. Gajewski;Hans Schreiber;Yang Xin Fu

  • The terminology issue for myeloid-derived suppressor cells.

    Dmitry I. Gabrilovich;Vincenzo Bronte;Shu Hsia Chen;Mario P. Colombo

  • Inflammation as a tumor promoter in cancer induction.

    Mary Philip;Donald A. Rowley;Hans Schreiber

  • Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

    Ping Yu;Youjin Lee;Wenhua Liu;Thomas Krausz

  • Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.

    Avery D. Posey;Robert D. Schwab;Alina C. Boesteanu;Catharina Steentoft

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.

    Markus Gerhard;Hartmut Juhl;Holger Kalthoff;Hans W. Schreiber

  • A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

    G Torre-Amione;R D Beauchamp;H Koeppen;B H Park

  • CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ

    Dominik Mumberg;Paul A. Monach;Sherry Wanderling;Mary Philip

  • Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

    J L Urban;H M Shepard;J L Rothstein;B J Sugarman

  • Inhibition of tumor growth by elimination of granulocytes.

    Lisa A. Pekarek;Barbara A. Starr;Alicia Y. Toledano;Hans Schreiber

  • Induced sensitization of tumor stroma leads to eradication of established cancer by T cells

    Bin Zhang;Natalie A. Bowerman;Joseph K. Salama;Hank Schmidt

  • Priming of naive T cells inside tumors leads to eradication of established tumors

    Ping Yu;Youjin Lee;Wenhua Liu;Robert K. Chin

  • Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.

    Jay L. Rothstein;Hans Schreiber

  • A unique tumor antigen produced by a single amino acid substitution.

    Paul A. Monach;Stephen C. Meredith;Christopher T.Siegel;Hans Schreiber

  • Bystander elimination of antigen loss variants in established tumors.

    Michael T Spiotto;Donald A Rowley;Hans Schreiber

  • Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.

    Michael T. Spiotto;Ping Yu;Donald A. Rowley;Michael I. Nishimura

  • Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.

    Maresa Wick;Purnima Dubey;Hartmut Koeppen;Christopher T. Siegel

  • Tumour ischaemia by interferon-γ resembles physiological blood vessel regression

    Thomas Kammertoens;Christian Friese;Christian Friese;Ainhoa Arina;Christian Idel

  • Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism

    Elena Loukinova;Gang Dong;Ileana Enamorado-Ayalya;Giovana R Thomas

Frequent Co-Authors

David M. Kranz
David M. Kranz University of Illinois at Urbana-Champaign
Yang-Xin Fu
Yang-Xin Fu Tsinghua University
Hans J. Stauss
Hans J. Stauss University College London
Ralph R. Weichselbaum
Ralph R. Weichselbaum University of Chicago
Stephen C. Meredith
Stephen C. Meredith University of Chicago
Theodore Karrison
Theodore Karrison University of Chicago
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
W. Martin Kast
W. Martin Kast University of Southern California
Henrik Clausen
Henrik Clausen University of Copenhagen
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare professions, particularly nursing. For those interested in advancing their clinical roles, exploring the cheapest pmhnp certificate programs can be a strategic pathway to specialize in psychiatric mental health alongside immunological studies.

Nurses aiming to expand their expertise might consider online programs designed to fast-track their career, such as the accelerated fnp programs, which help Family Nurse Practitioners gain advanced knowledge efficiently. Additionally, transitioning roles within nursing specializations is facilitated by options like the fnp to acnp bridge program online, offering a flexible path to acute care expertise that complements immunology-related clinical skills.

Understanding the financial outlook is also crucial. For instance, the dnp salary by specialty provides insight into how pursuing different nursing and healthcare degrees can impact long-term earning potential. This information helps prospective students align their educational investments with desired career outcomes in the health sciences.

Best Scientists Citing Hans Schreiber

Trending Scientists